EGFR and head and neck squamous cell carcinoma: Although several EGFR-targeting small molecule inhibitors and monoclonal antibodies are currently approved and under clinical evaluation for the treatment of human HNSCC 42, 43, clinical evaluation of agents targeting EGFR in feline OSCC has not been reported.